Switzerland Removes Medical Marijuana Access Limitations As Demand Rises
Cannabis In Cancer Treatment: Feds To Fund New Research In These Areas Of Interest
Cannabis-Based Sativex Mouth Spray To Treat Brain Tumors? Trial Gets Underway In England With Backing From National Health Services And Cancer Charities
VerdeMed Expands In Latin America With CBD Treatment, New Exec Team
Sativex Recent News
GW Pharma Obtains Exclusive UK Commercialization Rights To Sativex From Bayer
UK Recommends NHS Reimburse GW Pharma's CBD-Based Epilepsy Drug
GW Pharmaceuticals Sees 68% Q1 Revenue Growth Following Epidiolex Launch
GW Pharma Beats Q4 EPS Estimates, Misses On Revenue
Leerink Out Bullish On GW Pharma: 4 Reasons Why
5 Weed Stocks To Watch In 2018
GW Pharmaceuticals Takeover Talk 'Seems A Bit Premature'
GW Pharmaceuticals Falls 7% Following Disappointing Sativex Trial
GW Pharmaceuticals Kicks Back Up After Morgan Stanley Buys The Bottom
420 Investor Alan Brochstein: United States Has Led A Failed War On Drugs